Inventor · disambiguated record
Weijuan Kan
Also filed as: KAN WEIJUAN
3 granted patents·4 pending applications·0 citations·filing 2017–2023
36Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS4HANGZHOU HEALZEN THERAPEUTICS CO LTD1SHANGHAI INST OF METERIA MEDICA CHINESE ACADEMY OF SCIENCES1UNIV ZHEJIANG1
Top patents by PatentIndex Score
7 records- 0157US2025042862A1Aromatic heterocyclic compound and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0256US2025270202A1Substituted 4-aminoisoindoline compound, preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 0350US2024360146A1Bruton's tyrosine kinase and mutant degrader, composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0449US12404269B2Aminoquinazolinone and aminoisoquinolinone derivatives and application thereofUNIV ZHEJIANG·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 0546US2022041578A1Isoindoline compound, and preparation method, pharmaceutical composition, and application of isoindoline compoundSHANGHAI INST OF METERIA MEDICA CHINESE ACADEMY OF SCIENCES·Filed 2019·Application pending·0 cites
- 0637US11873292B2Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Jan 16, 2024·0 cites·10 claims
- 0736US12459921B2Isoindoline compound, preparation method, pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Nov 4, 2025·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Weijuan Kan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →